| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |